| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BeOne Medicines Ltd. | SVP, General Counsel | Ordinary Shares | 223,106 | $67,783,038 | $303.82 | 07 Jan 2026 | Direct |
| BeOne Medicines Ltd. | SVP, General Counsel | American Depositary Shares | 0 | $0 | $331.76 | 07 Jan 2026 | Direct |
| BeOne Medicines Ltd. | SVP, General Counsel | Share Option (Right to Buy) | 118,118 | 07 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ONC | BeOne Medicines Ltd. | 07 Jan 2026 | 7 | -$93,093 | 4 | SVP, General Counsel | 09 Jan 2026, 17:15 |
| ONC | BeOne Medicines Ltd. | 10 Dec 2025 | 14 | -$86,373 | 4 | SVP, General Counsel | 12 Dec 2025, 16:56 |
| ONC | BeOne Medicines Ltd. | 12 Nov 2025 | 8 | -$157,066 | 4 | SVP, General Counsel | 14 Nov 2025, 17:28 |
| ONC | BeOne Medicines Ltd. | 08 Oct 2025 | 10 | -$1,721,744 | 4 | SVP, General Counsel | 10 Oct 2025, 16:56 |
| ONC | BeOne Medicines Ltd. | 10 Sep 2025 | 11 | -$1,504,308 | 4 | SVP, General Counsel | 12 Sep 2025, 16:38 |
| ONC | BeOne Medicines Ltd. | 13 Aug 2025 | 7 | -$1,844,798 | 4 | SVP, General Counsel | 15 Aug 2025, 16:38 |
| ONC | BeOne Medicines Ltd. | 30 Jul 2025 | 1 | -$280,233 | 4 | SVP, General Counsel | 31 Jul 2025, 17:04 |
| ONC | BeOne Medicines Ltd. | 16 Jun 2025 | 1 | -$112,463 | 4 | SVP, General Counsel | 18 Jun 2025, 17:12 |
| ONC | BeOne Medicines Ltd. | 10 Jun 2025 | 2 | $0 | 4 | SVP, General Counsel | 12 Jun 2025, 17:49 |
| ONC | BeOne Medicines Ltd. | 06 Jun 2025 | 2 | -$179,280 | 4 | SVP, General Counsel | 10 Jun 2025, 16:57 |
| ONC | BeiGene, Ltd. | 05 Mar 2025 | 1 | $0 | 4 | SVP, General Counsel | 07 Mar 2025, 19:20 |
| ONC | BeiGene, Ltd. | 27 Feb 2025 | 1 | -$331,375 | 4 | SVP, General Counsel | 03 Mar 2025, 16:49 |
| ONC | BeiGene, Ltd. | 21 Feb 2025 | 3 | -$310,170 | 4 | SVP, General Counsel | 25 Feb 2025, 17:04 |
| ONC | BeiGene, Ltd. | 30 Sep 2024 | 1 | -$284,994 | 4 | SVP, General Counsel | 02 Oct 2024, 19:13 |
| ONC | BeiGene, Ltd. | 30 Jul 2024 | 1 | -$133,915 | 4 | SVP, General Counsel | 01 Aug 2024, 17:06 |
| ONC | BeiGene, Ltd. | 17 Jun 2024 | 3 | -$69,955 | 4 | SVP, General Counsel | 20 Jun 2024, 17:24 |
| ONC | BeiGene, Ltd. | 05 Jun 2024 | 2 | $0 | 4 | SVP, General Counsel | 07 Jun 2024, 17:03 |
| ONC | BeiGene, Ltd. | 31 Jul 2023 | 1 | -$171,059 | 4 | SVP, General Counsel | 02 Aug 2023, 17:10 |
| ONC | BeiGene, Ltd. | 15 Jun 2023 | 2 | $0 | 4 | SVP, General Counsel | 20 Jun 2023, 18:55 |
| ONC | BeiGene, Ltd. | 15 Jun 2023 | 0 | $0 | 3 | SVP, General Counsel | 20 Jun 2023, 18:37 |